The global coagulation/hemostasis analyzer market size is expected to be worth USD 4.84 billion by 2027, growing at a CAGR of 10.2% during the forecast period.
These analyzers are very much helpful in examining the hemostasis system in laboratories. Coagulometers are used in various methods, such as to observe blood clots in the blood. Coagulation analyzers follow easy steps to measure blood platelet levels. The early diagnosis of the hemostasis system can prevent blood clots which might cause heart attacks. Most importantly, coagulation analyzers can evaluate the thromboline and thromboplastin concentrations in very little time. Also, these analyzers are user-friendly as they can evaluate the required measurement in a few minutes, which helps prevent bleeding to blood clots.
MARKET DRIVERS:
The major factor driving the growth of the global coagulation/hemostasis analyzer market is the rising number of cardiovascular problems worldwide.
Changes in lifestyles and increasing obesity cases due to changes in food habits are also some common factors propelling the growth rate of the coagulation/hemostasis market. In addition, creating awareness over the availability of diagnostics procedures that can prevent heart attacks is enhancing the demand of this market. A growing number of people suffering from blood disorders is accelerating the market's growth rate to the extent.
Focus on developing innovative techniques and the rise in the number of research centers in the biotechnology field is to create growth opportunities for the coagulation/hemostasis analyzers market. The increasing prevalence of automation equipment in laboratories is greatly influencing the demand of the market eventually. The growing geriatric population is also one of the factors gearing up the growth rate of the market. Constant economic growth in both developed and developing countries is lucratively surging the demand of the market. Increasing investments in healthcare by private and public organizations are also impacting the market's demand towards positive.
MARKET RESTRAINTS:
Lack of standardization is slowly hindering the growth rate of the global coagulation/hemostasis analyzer market.
Automatic coagulation analyzers require huge amounts for installation and maintenance, which is remained a challenging factor for the market developers. Strict rules and regulations by government organizations in approving medical equipment also impede the growth rate of the coagulation/hemostasis analyzers market. The availability of alternative devices that are highly advanced at a lower price is quietly limiting the market demand. People in rural areas are less aware of these techniques due to a lack of proper knowledge in the analyzers' utilization, which is degrading the growth rate of the market.
REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2021 to 2027 |
|
Base Year |
2021 |
|
Forecast Period |
2022 to 2027 |
|
Segments Covered |
By Tests, Products, End Users, Technology and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Market Leaders Profiled |
Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Sysmex Corporation (Japan), Helena Laboratories (U.S.), Instrumentation Laboratory (U.S.), International Technidyne Corporation (U.S.), Nihon Kohden Corporation (Japan) and Diagnostica Stago (France). |
This research report on the global coagulation/hemostasis analyzer market has been segmented and sub-segmented into the following categories.
Coagulation/Hemostasis Analyzer Market - By Test:
Based on tests, prothrombin time testing has the largest market share in this segment. It is also the fastest-growing due to the increasing automation of this process in laboratories.
Coagulation/Hemostasis Analyzer Market - By Product:
Based on product, Clinical laboratory analyzers have the largest market in this segment.
Coagulation/Hemostasis Analyzer Market - By End Users:
Based on end-users, Clinical laboratories have the largest share in the segment.
Coagulation/Hemostasis Analyzer Market - By Technology:
Based on technology, the Optical segment has the largest market share and is also the fastest-growing segment.
Coagulation/Hemostasis Analyzer Market - By Region:
Geographically, the North American Market is expected to hold the largest share in the global market and had accounted for a 35.0% share in the global market during the forecast period. Factors such as an increase in lifestyle diseases such as obesity, diabetes, cardiovascular disorders, and the growing repetition of blood disorders are significant factors driving the North American market. In North America, the U.S. market is forecasted to lead during the forecast period, followed by Canada.
The European Market is expected to be the second-largest market in the global coagulation/hemostasis analyzer market during the forecast period. The factors driving the European market in the European region are the growing aging population, Y-O-Y growth in the incidence rate of chronic blood diseases, inactive lifestyle changes, and rising blood relevant disorders. The German market is predicted to dominate the European market during the forecast period.
The Asia-Pacific market is predicted to be the fastest-growing region in the global coagulation/hemostasis analyzer market. As a result of advancements in healthcare infrastructure in countries like China, Japan, and India, a growing number of general surgeries and an increasing number of research activities occur in few countries of the APAC region. China is predicted to showcase potentiality to grow with 12.7% in the forthcoming years.
The Latin American market is projected to perform well during the forecast period. Factors such as the growing number of people suffering from chronic blood disorders, an increasing number of hospitals and healthcare centers in Latin American are expected to boost the Latin American market growth. Moreover, growing investments in R&D activities, rising awareness among people regarding the advanced technologies further foster the Latin American hemostasis analyzer market. In Latin America, the Brazilian market is expected to play the leading role during the forecast period.
The Middle East & Africa Market is expected to have a sluggish growth rate during the forecast period.
KEY MARKET PLAYERS:
Some of the notable participants dominating the Global Coagulation/Hemostasis Analyzer Market Profiled in the Report are Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Sysmex Corporation (Japan), Helena Laboratories (U.S.), Instrumentation Laboratory (U.S.), International Technidyne Corporation (U.S.), Nihon Kohden Corporation (Japan) and Diagnostica Stago (France).
RECENT MARKET DEVELOPMENTS:
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Test
5.1.1 ACT
5.1.2 aPTT
5.1.3 D Dimer testing
5.1.4 Platelet Function Test
5.1.5 Prothrombin Time Testing
5.1.6 Anti-Factor Xa Test
5.1.7 Heparin and Protamine Dose Response Test for ACT
5.1.8 Fibrinogen Testing
5.1.9 Other Coagulation Tests
5.1.10 Y-o-Y Growth Analysis, By Test
5.1.11 Market Attractiveness Analysis, By Test
5.1.12 Market Share Analysis, By Test
5.2 Product
5.2.1 PoC Testing Analyzers
5.2.2 Clinical Laboratory Analyzers
5.3 End Users
5.3.1 Clinical Laboratories
5.3.2 Point-Of-Care Testing
5.3.3 Other End Users
5.3.4 Y-o-Y Growth Analysis, By End Users
5.3.5 Market Attractiveness Analysis, By End Users
5.3.6 Market Share Analysis, By End Users
5.4 Technology
5.4.1 Electrochemical Technology
5.4.2 Optical Technology
5.4.3 Mechanical Technology
5.4.4 Other Technologies
5.4.5 Y-o-Y Growth Analysis, By Technology
5.4.6 Market Attractiveness Analysis, By Technology
5.4.7 Market Share Analysis, By Technology
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Test
6.1.3.2 By Product
6.1.3.3 By End Users
6.1.3.4 By Technology
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Test
6.1.4.2 By Product
6.1.4.3 By End Users
6.1.4.4 By Technology
6.1.5 Market Share Analysis
6.1.5.1 By Test
6.1.5.2 By Product
6.1.5.3 By End Users
6.1.5.4 By Technology
6.2 North America
6.2.1 Introduction
6.2.2 United States
6.2.3 Canada
6.3 Europe
6.3.1 Introduction
6.3.2 U.K
6.3.3 Spain
6.3.4 Germany
6.3.5 Italy
6.3.6 France
6.4 Asia-Pacific
6.4.1 Introduction
6.4.2 China
6.4.3 India
6.4.4 Japan
6.4.5 Australia
6.4.6 South Korea
6.5 Latin America
6.5.1 Introduction
6.5.2 Brazil
6.5.3 Argentina
6.5.4 Mexico
6.5.5 Rest of Latin America
6.6 Middle East & Africa
6.6.1 Introduction
6.6.2 Middle-East
6.6.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Siemens AG
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Thermo Fisher Scientific Inc.
8.3 Roche Diagnostics
8.4 Alere Inc.
8.5 Sysmex Corporation
8.6 Helena Laboratories
8.7 Instrumentation Laboratory
8.8 International Technidyne Corporation
8.9 Nihon Kohden Corporation
8.10 Diagnostica Stago
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
